Skip to main content

Advertisement

Log in

Understanding hepatic encephalopathy

Intensive Care Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Mouri S, Tripon S, Rudler M et al (2015) Four score, a reliable score for assessing overt hepatic encephalopathy in cirrhotic patients. Neurocrit Care 22:251–257

    Article  PubMed  CAS  Google Scholar 

  2. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT (2002) Hepatic encephalopathy—definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 35:716–721

    Article  PubMed  Google Scholar 

  3. Holecek M (2015) Ammonia and amino acid profiles in liver cirrhosis: effects of variables leading to hepatic encephalopathy. Nutrition 31:14–20

    Article  PubMed  CAS  Google Scholar 

  4. Romero-Gómez M, Jover M, Del Campo JA et al (2010) Variations in the promoter region of the glutaminase gene and the development of hepatic encephalopathy in patients with cirrhosis: a cohort study. Ann Intern Med 153:281–288

    Article  PubMed  Google Scholar 

  5. Romero-Gómez M, Montagnese S, Jalan R (2015) Hepatic encephalopathy in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure. J Hepatol 62:437–447

    Article  PubMed  CAS  Google Scholar 

  6. Weiss N, Rosselli M, Mouri S et al (2016) Modification in CSF specific gravity in acutely decompensated cirrhosis and acute on chronic liver failure independent of encephalopathy, evidences for an early blood-CSF barrier dysfunction in cirrhosis. Metab Brain Dis. doi:10.1007/s11011-016-9916-9

    Article  PubMed  Google Scholar 

  7. Selvapatt N, Singanayagam A, Wendon J, Antoniades CG (2014) Understanding infection susceptibility in patients with acute-on-chronic liver failure. Intensive Care Med 40:1363–1366

    Article  PubMed  Google Scholar 

  8. Palomero-Gallagher N, Zilles K (2013) Neurotransmitter receptor alterations in hepatic encephalopathy: a review. Arch Biochem Biophys 536:109–121

    Article  PubMed  CAS  Google Scholar 

  9. Weiss N, Barbier Saint Hilaire P, Colsch B et al (2016) Cerebrospinal fluid metabolomics highlights dysregulation of energy metabolism in overt hepatic encephalopathy. J Hepatol 65:1120–1130

    Article  PubMed  CAS  Google Scholar 

  10. Shawcross DL, Davies NA, Williams R, Jalan R (2004) Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. J Hepatol 40:247–254

    Article  PubMed  CAS  Google Scholar 

  11. Thabut D, Massard J, Gangloff A et al (2007) Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure. Hepatology 46:1872–1882

    Article  PubMed  Google Scholar 

  12. Bajaj JS, O’Leary JG, Reddy KR et al (2012) Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American consortium for the study of end-stage liver disease (NACSELD) experience. Hepatology 56:2328–2335

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  13. Wasmuth HE, Kunz D, Yagmur E et al (2005) Patients with acute on chronic liver failure display “sepsis-like” immune paralysis. J Hepatol 42:195–201

    Article  PubMed  CAS  Google Scholar 

  14. Berry PA, Antoniades CG, Carey I et al (2011) Severity of the compensatory anti-inflammatory response determined by monocyte HLA-DR expression may assist outcome prediction in cirrhosis. Intensive Care Med 37:453–460

    Article  PubMed  CAS  Google Scholar 

  15. Weiss N, Junot C, Rudler M et al (2016) Hepatic vs. drug-induced encephalopathy in cirrhotic patients? Liver Int 36:1233–1234

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nicolas Weiss.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Weiss, N., Jalan, R. & Thabut, D. Understanding hepatic encephalopathy. Intensive Care Med 44, 231–234 (2018). https://doi.org/10.1007/s00134-017-4845-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-017-4845-6

Keywords

Navigation